KPV supplements have gained attention for their potential role in modulating inflammation and promoting tissue repair. One of the key components often highlighted in discussions about KPV is the Thymosin Beta-4 Fragment, also known as Ac-SDKP. This peptide has been studied extensively for its anti-inflammatory properties, its ability to influence cellular migration, and its involvement in cardiovascular health.
Thymosin Beta-4 Fragment (Ac-SDKP)
The Thymosin Beta-4 Fragment is a tetrapeptide derived from the larger thymosin beta-4 protein. Its sequence is Acetyl-serine-aspartate-lysine-proline, hence the abbreviation Ac-SDKP. This small peptide has been shown to have potent biological activities despite its size. In vitro studies indicate that Ac-SDKP can inhibit the proliferation of certain cell types and reduce the expression of pro-inflammatory cytokines such as tumor necrosis factor alpha and interleukin-6. In addition, it modulates signaling pathways related to fibrosis, thereby reducing extracellular matrix deposition in damaged tissues.
The peptide’s anti-apoptotic effects are also notable
1
Ac SDKP: The Functional Peptide Derived from Thymosin β 4
jenniferhibbin edited this page 2025-10-17 09:54:48 +02:00